Summary
Procter & Gamble reported mixed results for the period ending December 30, 2016. While net sales remained flat year-over-year for both the quarter and the year-to-date period, the company experienced a significant increase in net earnings attributable to P&G. This surge was primarily driven by a substantial after-tax gain of $5.3 billion from the divestiture of its Beauty Brands to Coty. Excluding this one-time gain and other non-recurring items like debt extinguishment charges, the company's 'Core Net Earnings' showed modest growth, indicating underlying operational stability. Despite flat top-line performance, the company saw positive organic sales growth of 2% for the year-to-date period, driven by a 1% increase in unit volume. This growth was broad-based across most segments, with Health Care showing particularly strong performance. However, net earnings from continuing operations experienced a slight decline, impacted by a charge related to the early extinguishment of long-term debt and unfavorable foreign exchange movements. Investors should note the ongoing portfolio transformation with the divestiture of non-core assets and a focus on cost savings and productivity initiatives, which are expected to support future profitability.
Financial Highlights
53 data points| Revenue | $16.86B |
| Cost of Revenue | $8.30B |
| Gross Profit | $8.56B |
| SG&A Expenses | $4.68B |
| Operating Income | $3.88B |
| Interest Expense | $122.00M |
| Net Income | $7.88B |
| EPS (Basic) | $3.01 |
| EPS (Diluted) | $2.88 |
| Shares Outstanding (Basic) | 2.60B |
| Shares Outstanding (Diluted) | 2.74B |
Key Highlights
- 1Net sales remained flat at $16.9 billion for the three months ended December 31, 2016, and $33.4 billion for the six months ended December 31, 2016, compared to the prior year periods.
- 2Net earnings attributable to Procter & Gamble surged by 146% for the quarter and 82% for the year-to-date period, primarily due to a $5.3 billion after-tax gain from the sale of Beauty Brands.
- 3Net earnings from continuing operations decreased by 12% for the quarter and 4% for the year-to-date period, largely impacted by a $345 million charge related to early extinguishment of long-term debt.
- 4Organic sales grew by 2% for both the three-month and six-month periods, driven by a 1% increase in unit volume.
- 5Health Care segment demonstrated strong performance with a 5% net sales increase in the quarter and 4% year-to-date, alongside positive earnings growth.
- 6The company continued its portfolio transformation, with the significant divestiture of its Beauty Brands completed during the period.
- 7Core net earnings per share (EPS) increased by 4% for both the three-month and six-month periods, indicating underlying business resilience excluding one-time items.